Skip to main content
. 2020 Feb 24;10:3229. doi: 10.1038/s41598-020-60213-0

Figure 5.

Figure 5

Metformin reduced IFN-α expression in primary human PBMCs via the mTORC1 pathway. (a) Peripheral blood mononuclear cells (PBMCs) from non-DM individuals (n = 5) were treated with metformin (Met) or rapamycin (Rapa) for 30 min. Drug-treated PBMCs were incubated with poly I:C or influenza whole-virion for 3 h before RNA extraction. IFN-α mRNA expression was determined by real-time PCR. Expression is shown as fold expression. Each point represents an individual. Statistical analyses were undertaken using one-way ANOVA. Horizontal lines represent the median and interquartile range. (b) The same PBMC samples were treated with Met or Rapa for 30 min before incubation with influenza whole-virion for 3 h, followed by determination of total p70S6k and P-p70S6K (Thr389) by western blotting. The data are representative of three individuals. (c) Relative density of p70S6K. (d) Ratio of relative density of P-p70S6K/p70S6K. Each colour bar represents each condition. Each dot represents an individual. The bar graph represents mean values. Statistical analyses were carried out using two-way ANOVA, *p < 0.05, **p < 0.01, ****p < 0.0001.